Shepherd Center announced today that it is now a treatment site for Proneuron's Phase II, multi-center, randomized-controlled trial of ProCord for complete spinal cord injury. Shepherd Center has been enrolling patients in the study as an IRB patient referral and follow up site for more than a year. With the completion of the establishment and operation of a specially designed cell processing center at Cell Design LLC in Atlanta, Shepherd Center has the necessary tools to implement the surgical segment of the experimental therapy.
"The ProCord trial continues and is currently live at Shepherd Center. We are now fully equipped to provide both the surgical and the post-operative rehabilitation portions of this experimental treatment. We look forward to continuing our participation in this very important research," said David Apple, Jr., MD, Emeritus Medical Director of Shepherd Center.
http://www.genengnews.com/news/bnitem.aspx?name=536329XSL_NEWSML_TO_NEWSML_WEB.xml